Sruthi Ravindranathan

756 total citations
28 papers, 507 citations indexed

About

Sruthi Ravindranathan is a scholar working on Oncology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sruthi Ravindranathan has authored 28 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Immunology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sruthi Ravindranathan's work include CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (7 papers). Sruthi Ravindranathan is often cited by papers focused on CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (7 papers). Sruthi Ravindranathan collaborates with scholars based in United States, Ireland and China. Sruthi Ravindranathan's co-authors include David A. Zaharoff, Sean G. Smith, Bhanu Koppolu, Srinivas Jayanthi, Thallapuranam Krishnaswamy Suresh Kumar, Khue G. Nguyen, Edmund K. Waller, Lirong Yang, Christopher R. Flowers and Narasimhan Rajaram and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sruthi Ravindranathan

28 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sruthi Ravindranathan United States 10 194 176 163 99 97 28 507
Isabella Monia Montagner Italy 12 183 0.9× 121 0.7× 186 1.1× 86 0.9× 66 0.7× 23 484
Neha Kapate United States 11 104 0.5× 193 1.1× 256 1.6× 156 1.6× 287 3.0× 16 699
Ece Tavukçuoğlu Türkiye 16 161 0.8× 176 1.0× 169 1.0× 124 1.3× 80 0.8× 26 505
Yingyue Ding United States 5 132 0.7× 271 1.5× 287 1.8× 126 1.3× 309 3.2× 6 691
Michael Fichter Germany 13 257 1.3× 261 1.5× 252 1.5× 148 1.5× 185 1.9× 30 781
Hannah L. O’Mary United States 9 75 0.4× 200 1.1× 251 1.5× 150 1.5× 150 1.5× 10 564
Matthias P. Domogalla Germany 7 101 0.5× 355 2.0× 241 1.5× 174 1.8× 134 1.4× 9 731
Na Kyeong Lee South Korea 16 112 0.6× 181 1.0× 358 2.2× 175 1.8× 206 2.1× 34 765
Parisa Yousefpour United States 10 147 0.8× 169 1.0× 309 1.9× 222 2.2× 168 1.7× 18 655
Syahril Abdullah Malaysia 16 94 0.5× 95 0.5× 511 3.1× 145 1.5× 107 1.1× 53 901

Countries citing papers authored by Sruthi Ravindranathan

Since Specialization
Citations

This map shows the geographic impact of Sruthi Ravindranathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sruthi Ravindranathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sruthi Ravindranathan more than expected).

Fields of papers citing papers by Sruthi Ravindranathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sruthi Ravindranathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sruthi Ravindranathan. The network helps show where Sruthi Ravindranathan may publish in the future.

Co-authorship network of co-authors of Sruthi Ravindranathan

This figure shows the co-authorship network connecting the top 25 collaborators of Sruthi Ravindranathan. A scholar is included among the top collaborators of Sruthi Ravindranathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sruthi Ravindranathan. Sruthi Ravindranathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, William, Subir Goyal, Tongrui Liu, et al.. (2024). Antagonizing vasoactive intestinal peptide (VIP) receptors with Muc16CD-directed armored CAR T cells for pancreatic cancer.. Journal of Clinical Oncology. 42(16_suppl). 2558–2558. 1 indexed citations
2.
Zhang, Hanwen, et al.. (2024). VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer. Cancer Research. 84(18). 2954–2967. 4 indexed citations
3.
Rajasekaran, Narendiran, Xiaoguang Wang, Sruthi Ravindranathan, et al.. (2024). Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells. Cancer Immunology Immunotherapy. 73(3). 60–60. 17 indexed citations
4.
Paidi, Santosh Kumar, Khue G. Nguyen, Sruthi Ravindranathan, et al.. (2023). Evaluating differences in optical properties of indolent and aggressive murine breast tumors using quantitative diffuse reflectance spectroscopy. Biomedical Optics Express. 14(12). 6114–6114. 2 indexed citations
5.
Ravindranathan, Sruthi, Xiaoguang Wang, Daniel J. Chin, et al.. (2023). 468 Characteristics of toripalimab: a next generation anti-PD-1 antibody with potent T cell activation and enhanced clinical efficacy irrespective of PD-L-1 status. SHILAP Revista de lepidopterología. A522–A526. 1 indexed citations
6.
Zhang, Hanwen, Sruthi Ravindranathan, Ramireddy Bommireddy, et al.. (2023). The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy. Frontiers in Immunology. 14. 1154566–1154566. 5 indexed citations
7.
Zhang, Hanwen, Khanjan Gandhi, Sruthi Ravindranathan, et al.. (2022). Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression. Blood. 140(12). 1431–1447. 9 indexed citations
8.
Sharma, Aditi, Vikas A. Gupta, Shanmuganathan Chandrakasan, et al.. (2022). PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity. Blood. 139(4). 523–537. 91 indexed citations
9.
Paidi, Santosh Kumar, Khue G. Nguyen, Sruthi Ravindranathan, et al.. (2022). Raman spectroscopy reveals phenotype switches in breast cancer metastasis. Theranostics. 12(12). 5351–5363. 23 indexed citations
10.
Ravindranathan, Sruthi, Hanwen Zhang, Caitlin Taylor, et al.. (2022). Passenger pathogens on physicians. American Journal of Infection Control. 51(7). 807–811. 1 indexed citations
11.
Ravindranathan, Sruthi, et al.. (2021). PI3K δ /γ Inhibition Enhances the Expansion and Anti-Tumor Cytotoxicity of CART Cells for CLL Patients. Blood. 138(Supplement 1). 4795–4795. 2 indexed citations
12.
Ravindranathan, Sruthi, Sanjay Chandrasekaran, Mohammad Y. Zaidi, et al.. (2020). 819 Targeting vasoactive intestinal peptide receptor signaling: a novel approach to enhance anti-tumor response in pancreatic ductal adenocarcinoma. SHILAP Revista de lepidopterología. A489–A491. 2 indexed citations
13.
Ravindranathan, Sruthi, Yiwen Li, Shuhua Wang, et al.. (2019). Abstract 1205: Targeting vasoactive intestinal peptide signaling to enhance pancreatic cancer responsiveness to immunotherapy. Cancer Research. 79(13_Supplement). 1205–1205. 1 indexed citations
14.
Ravindranathan, Sruthi, Khue G. Nguyen, Sean G. Smith, et al.. (2018). Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines. Breast Cancer Research. 20(1). 126–126. 29 indexed citations
15.
Smith, Sean G., et al.. (2016). Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer. OncoImmunology. 6(1). e1259050–e1259050. 29 indexed citations
16.
Smith, Sean G., Bhanu Koppolu, Sruthi Ravindranathan, et al.. (2015). Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer. Cancer Immunology Immunotherapy. 64(6). 689–696. 36 indexed citations
17.
Ravindranathan, Sruthi, Sean G. Smith, Khue G. Nguyen, & David A. Zaharoff. (2015). Colony stimulating factors secreted by irradiated autologous tumor cell vaccines inhibit immunity. Journal for ImmunoTherapy of Cancer. 3(S2). 2 indexed citations
18.
Koppolu, Bhanu, Sean G. Smith, Sruthi Ravindranathan, et al.. (2014). Controlling chitosan-based encapsulation for protein and vaccine delivery. Biomaterials. 35(14). 4382–4389. 116 indexed citations
19.
Ravindranathan, Sruthi, et al.. (2014). Current status of autologous breast tumor cell-based vaccines. Expert Review of Vaccines. 13(12). 1439–1445. 21 indexed citations
20.
Yang, Lirong, et al.. (2014). Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis. OncoImmunology. 3(12). e968001–e968001. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabella Monia Montagner Breakdown of academic impact, for papers by Neha Kapate Breakdown of academic impact, for papers by Ece Tavukçuoğlu Breakdown of academic impact, for papers by Yingyue Ding Breakdown of academic impact, for papers by Michael Fichter Breakdown of academic impact, for papers by Hannah L. O’Mary Breakdown of academic impact, for papers by Matthias P. Domogalla Breakdown of academic impact, for papers by Na Kyeong Lee Breakdown of academic impact, for papers by Parisa Yousefpour Breakdown of academic impact, for papers by Syahril Abdullah
Rankless by CCL
2026